1. Home
  2. CASS vs TYRA Comparison

CASS vs TYRA Comparison

Compare CASS & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASS
  • TYRA
  • Stock Information
  • Founded
  • CASS 1906
  • TYRA 2018
  • Country
  • CASS United States
  • TYRA United States
  • Employees
  • CASS N/A
  • TYRA N/A
  • Industry
  • CASS Business Services
  • TYRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CASS Consumer Discretionary
  • TYRA Health Care
  • Exchange
  • CASS Nasdaq
  • TYRA Nasdaq
  • Market Cap
  • CASS 567.9M
  • TYRA 580.2M
  • IPO Year
  • CASS 1996
  • TYRA 2021
  • Fundamental
  • Price
  • CASS $39.63
  • TYRA $10.37
  • Analyst Decision
  • CASS Buy
  • TYRA Strong Buy
  • Analyst Count
  • CASS 2
  • TYRA 7
  • Target Price
  • CASS $48.00
  • TYRA $30.86
  • AVG Volume (30 Days)
  • CASS 64.8K
  • TYRA 241.1K
  • Earning Date
  • CASS 07-17-2025
  • TYRA 08-11-2025
  • Dividend Yield
  • CASS 3.13%
  • TYRA N/A
  • EPS Growth
  • CASS N/A
  • TYRA N/A
  • EPS
  • CASS 1.86
  • TYRA N/A
  • Revenue
  • CASS $219,841,000.00
  • TYRA N/A
  • Revenue This Year
  • CASS N/A
  • TYRA N/A
  • Revenue Next Year
  • CASS $7.81
  • TYRA N/A
  • P/E Ratio
  • CASS $25.13
  • TYRA N/A
  • Revenue Growth
  • CASS 2.79
  • TYRA N/A
  • 52 Week Low
  • CASS $37.99
  • TYRA $6.42
  • 52 Week High
  • CASS $47.14
  • TYRA $29.60
  • Technical
  • Relative Strength Index (RSI)
  • CASS 28.39
  • TYRA 48.30
  • Support Level
  • CASS $41.14
  • TYRA $10.71
  • Resistance Level
  • CASS $42.34
  • TYRA $11.66
  • Average True Range (ATR)
  • CASS 1.21
  • TYRA 0.63
  • MACD
  • CASS -0.51
  • TYRA -0.01
  • Stochastic Oscillator
  • CASS 11.60
  • TYRA 18.25

About CASS Cass Information Systems Inc

Cass Information Systems Inc is a provider of payment and information processing services to large manufacturing, distribution and retail enterprises across the United States. The company provides transportation invoice rating, payment processing, auditing, accounting, and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility-related expenses. It operates in two segments: Information Services and Banking Services. The firm generates maximum revenue from the Information Services segment, which provides transportation, energy, telecommunication, and environmental invoice processing and payment services to large corporations.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: